Resotran 540 mg / ml

Resotran 540 mg / ml is a medicine authorised by Swissmedic under authorisation number 69866. The authorisation holder is b.e.imaging.ag. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 July 2025 and the authorisation is limited until 15 July 2030. ATC code V08CB03 places the medicine in the group Contrast media.

  • Dispensing category B
  • Authorisation number 69866
  • ATC V08CB03
  • Synthetic medicines
Authorisation data
Authorisation number69866
NameResotran 540 mg / ml
Full nameResotran 540 mg / ml, Injektionssuspension
Authorisation holderb.e.imaging.ag
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeV08CB03
First authorisation16 July 2025
Authorisation validity15 July 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Resotran 540 mg / ml, InjektionssuspensionB16 July 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11,5mlV08CB0314.02.0.B

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Resotran 540 mg / ml authorised in Switzerland?

Yes. Resotran 540 mg / ml is authorised by Swissmedic under authorisation number 69866, data as of 01 September 2026. The authorisation is limited until 15 July 2030.

Which dispensing category does Resotran 540 mg / ml have?

Resotran 540 mg / ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Resotran 540 mg / ml?

The authorisation holder is b.e.imaging.ag. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com